4.7 Article

Protein labeling with the labeling precursor [18F] SiFA-SH for positron emission tomography

Journal

NATURE PROTOCOLS
Volume 7, Issue 11, Pages 1964-1969

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nprot.2012.111

Keywords

-

Funding

  1. Canada Foundation for Innovation project [203639]
  2. Natural Sciences and Engineering Research Council of Canada (NSERC) Strategic Project Grant Program (STPGP) [412893]
  3. Bayern-Quebec-Allianz
  4. Deutsche Forschungsgemeinschaft (DFG) [WA 2132/3-1]
  5. Fonds der Chemischen Industrie

Ask authors/readers for more resources

Proteins previously derivatized with the cross-coupling reagent sulfo-SMCC (4-(N-maleimidomethyl) cyclohexane-1-carboxylic acid 3-sulfo-N-hydroxy-succinimide ester sodium salt) can be easily labeled in high radiochemical yields with the silicon-fluoride acceptor (SiFA) reagent [F-18] SiFA-SH, obtained via isotopic exchange, by thiol-maleimide coupling chemistry (n = 10). The specific activity of SiFA-SH obtained in a one-step labeling reaction was > 18.5 GBq mu mol(-1) (> 500 Ci mmol(-1)). The number of SiFA building blocks per protein molecule is defined by the previously introduced number of maleimide groups, which can be determined by a simple and convenient Ellman's assay. Not more than two maleimide groups are introduced using sulfo-SMCC, thereby keeping the modification of the protein low and preserving its biological activity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Molecular imaging of cardiac CXCR4 expression in a mouse model of acute myocardial infarction using a novel 68Ga-mCXCL12 PET tracer

Mathias Johannes Zacherl, Andrei Todica, Carmen Wngler, Ralf Schirrmacher, Mohammad Ali Hajebrahimi, Joachim Pircher, Xiang Li, Simon Lindner, Matthias Brendel, Peter Bartenstein, Steffen Massberg, Stefan Brunner, Sebastian Lehner, Marcus Hacker, Bruno C. Huber

Summary: The study shows the feasibility of noninvasive molecular imaging of cardiac CXCR4 expression using a novel, murine-based, and specific (68)Ga-mCXCL12 tracer both ex vivo and in vivo, with consistent results.

JOURNAL OF NUCLEAR CARDIOLOGY (2021)

Review Chemistry, Medicinal

Recent Advances in the Clinical Translation of Silicon Fluoride Acceptor (SiFA) 18F-Radiopharmaceuticals

Lexi Gower-Fry, Travis Kronemann, Andreas Dorian, Yinglan Pu, Carolin Jaworski, Carmen Waengler, Peter Bartenstein, Leonie Beyer, Simon Lindner, Klaus Jurkschat, Bjoern Waengler, Justin J. Bailey, Ralf Schirrmacher

Summary: Incorporation of silicon fluoride acceptor (SiFA) moieties into various molecules has enhanced the generation of F-18 radiopharmaceuticals for medical imaging. The efficient isotopic exchange radiofluorination process, along with the enhanced in vivo stability of [F-18]SiFA, makes it a suitable strategy for fluorine-18 incorporation. This review emphasizes the clinical applicability of [F-18]SiFA-labeled compounds and discusses significant radiotracers currently in clinical use.

PHARMACEUTICALS (2021)

Article Chemistry, Medicinal

The Exception That Proves the Rule: How Sodium Chelation Can Alter the Charge-Cell Binding Correlation of Fluorescein-Based Multimodal Imaging Agents

Marco Maspero, Clelia Dallanoce, Bjoern Waengler, Carmen Waengler, Ralph Huebner

Summary: In this study, we describe and explain the aberrant behavior in receptor binding profile of a fluorescein-based multimodal imaging agent for gastrin releasing peptide receptor (GRPR) visualization by elucidating a chelating mechanism on sodium ions of its fluorescent dye moiety.

CHEMMEDCHEM (2022)

Article Chemistry, Medicinal

Synthesis and Preclinical Evaluation of [18F]SiFA-PSMA Inhibitors in a Prostate Cancer Model

Justin J. Bailey, Melinda Wuest, Michael Wagner, Atul Bhardwaj, Carmen Waengler, Bjoern Waengler, John F. Valliant, Ralf Schirrmacher, Frank Wuest

Summary: PET imaging using Ga-68 and F-18 radiotracers targeting PSMA has gained significant interest, with novel F-18-labeled SiFA-bearing PSMA inhibitors being synthesized and tested for their in vitro binding. Among the compounds, [F-18]SiFA-Asp2-PEG3-PSMA showed the highest tumor uptake in LNCaP tumors. Increased molar activity led to a significant increase in tumor uptake, and the SiFA-isotopic exchange chemistry offers a promising method for clinical translation.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Multidisciplinary

Toward the Development of GE11-Based Radioligands for Imaging of Epidermal Growth Factor Receptor-Positive Tumors

Benedikt Judmann, Diana Braun, Ralf Schirrmacher, Bjoern Wangler, Carmen Wangler, Gert Fricker

Summary: The study suggests that GE11-based monovalent and small homomultivalent radiotracers have limited affinity for EGFR and are not promising for further development as radioligands.

ACS OMEGA (2022)

Article Chemistry, Medicinal

Synthesis of a Bifunctional Cross-Bridged Chelating Agent, Peptide Conjugation, and Comparison of 68Ga Labeling and Complex Stability Characteristics with Established Chelators

Helen Damerow, Bjoern Waengler, Ralf Schirrmacher, Gert Fricker, Carmen Waengler

Summary: Different chelators can be used to introduce [Ga-68]Ga3+ into receptor-specific peptidic carriers for radiotracer imaging, and the choice of chelating agent significantly affects the in vivo pharmacokinetics of the radiopeptides. A backbone-functionalized variant of the chelator CB-DO2A, CB-DO2A-GA, was developed as a valuable alternative to established chelating agents for Ga-68-radiolabeling of peptides. It was found that CB-DO2A-GA required harsher reaction conditions for Ga-68-incorporation compared to DOTA, NODA-GA, and DOTA-GA.

CHEMMEDCHEM (2023)

Article Pharmacology & Pharmacy

Toward Optimized 89Zr-Immuno-PET: Side-by-Side Comparison of [89Zr]Zr-DFO-, [89Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [89Zr]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable?

Helen Damerow, Xia Cheng, Valeska von Kiedrowski, Ralf Schirrmacher, Bjoern Waengler, Gert Fricker, Carmen Waengler

Summary: Zr-89 is a highly favorable positron emitter for immuno-PET imaging. Complexation of the Zr-89(4+) ion with desferrioxamine B is commonly used to introduce the ion into antibodies, but the complexes have limited kinetic inertness. Therefore, new chelators, such as DFO* and 3,4,3-(LI-1,2-HOPO), have been developed. Comparisons between these chelators have shown that DFO* is the most suitable candidate for stable Zr-89 labeling of antibodies for clinical translation.

PHARMACEUTICS (2022)

Article Chemistry, Medicinal

Towards Radiolabeled EGFR-Specific Peptides: Alternatives to GE11

Benedikt Judmann, Bjorn Waengler, Ralf Schirrmacher, Gert Fricker, Carmen Waengler

Summary: This study investigated whether certain peptidic radiotracers can specifically target EGFR-positive tumors. The results showed that these radiotracers failed to demonstrate the ability to specifically target EGFR-positive tumors, suggesting the need for further exploration of alternative radiotracers.

PHARMACEUTICALS (2023)

Review Chemistry, Medicinal

Type I inhibitors of tropomyosin receptor kinase (Trk): a 2020-2022 patent update

Carolin Jaworski, Petar Iliev, Carmen Waengler, Bjoern Waengler, Brent Page, Ralf Schirrmacher, Justin J. Bailey

Summary: Trk inhibitors are significant in personalized medicine as they target specific genetic alterations, leading to improved treatment outcomes for cancer patients. Efforts are being made to enhance efficacy and reduce toxicity.

EXPERT OPINION ON THERAPEUTIC PATENTS (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Performance assessment of the ALBIRA II pre-clinical SPECT S102 system for 99mTc imaging

Ali Asgar Attarwala, Deni Hardiansyah, Chiara Romano, Luis David Jimenez-Franco, Mareike Roscher, Bjoern Waengler, Gerhard Glatting

Summary: The performance characteristics of the SPECT sub-system S102 of the ALBIRA II PET/SPECT/CT for the 80 mm field of view were analyzed, showing favorable sensitivity and spatial resolution for small animal imaging.

ANNALS OF NUCLEAR MEDICINE (2021)

No Data Available